Berberine ursodeoxycholate(Cat No.:I043419)is a hybrid compound that combines berberine, a natural alkaloid known for its antimicrobial, anti-inflammatory, and metabolic benefits, with ursodeoxycholic acid (UDCA), a bile acid used to treat liver conditions. This combination is being studied for its potential to enhance liver health by promoting bile flow, reducing liver inflammation, and improving lipid metabolism. Berberine ursodeoxycholate may also help manage metabolic disorders like diabetes and non-alcoholic fatty liver disease (NAFLD). Research is ongoing to evaluate its safety, efficacy, and therapeutic potential in treating liver-related diseases and metabolic conditions.